Onderzoek

Personalised Treatment
Because no two patients are the same
Every person is different - so why treat them the same? At HTRIC, we are transforming how patients are treated by moving beyond one-size-fits-all medicine. Our goal is simple but powerful: to deliver the right treatment, to the right person, at the right time.
With the help of artificial intelligence and advanced diagnostics, we can analyze complex layers of data, from a patient’s genes to their metabolism and molecular imaging profiles. This approach, known as integrated omics, allows us to:
- Understand the biological roots of disease in each individual
- Identify precise treatment targets
- Predict how a person will respond to a therapy
By combining molecular imaging with AI-driven analysis, we create detailed personal health profiles that guide treatment decisions with unmatched accuracy.
Toonaangevende voorbeelden:

HTRIC is helping develop a new wave of targeted treatments that minimize side effects and maximize results. These include:
- Nanoparticles and nanomedicines that deliver drugs exactly where they are needed – no more, no less
- Immunotherapy that harnesses the patient’s own immune system to fight cancer and other diseases
- Fluorescence-guided surgery that helps surgeons see and remove tumors with extreme precision
- High-intensity focused ultrasound that can destroy diseased tissue without invasive surgery
- Micro- and nanorobots – tiny biological machines that navigate the body to deliver treatments with pinpoint accuracy, transforming surgery, imaging, and drug delivery
Personalized treatment is not just about technology, it is about better outcomes for real people. When care is tailored to the individual, patients heal faster, experience fewer side effects, and have a higher quality of life.
At HTRIC, we are building a future where personalized care is the standard, not the exception.
- Ecosysteem partners: W.J. Kolff, ENTEG, Bernoulli Instituut, DSSC, DASH, HG, SPRINT, Lode Holding, Philips, Oro Muscles (voorheen BlackTop Labs BV)
- Toekomstkans: De ontwikkeling van zelflerende systemen
- Technologie: Sensoren, Machine Learning, AI, Big Data